Are you Dr. Choi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 23 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Haesun Choi, MD is a board certified nuclear medicine physician in Houston, Texas. She is currently licensed to practice medicine in Texas, Iowa, and Alabama. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
USA HealthResidency, Radiology-Diagnostic, 1987 - 1989
University of Iowa Hospitals and ClinicsResidency, Nuclear Medicine, 1984 - 1987
Hanyang University College of MedicineClass of 1979
Certifications & Licensure
TX State Medical License 1992 - 2024
IA State Medical License 1984 - 2005
AL State Medical License Active through 2001- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Clinical Trials
- A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast Start of enrollment: 2005 Jul 01
- 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate Start of enrollment: 2007 Jan 01
- 3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsRepeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).Michael A Boss, Bradley S Snyder, Eunhee Kim, Dena Flamini, Sarah Englander, Karthik M Sundaram, Naveen Gumpeni, Suzanne L Palmer, Haesun Choi, Adam T Froemming, Thors...> ;Journal of Magnetic Resonance Imaging. 2022 Sep 1
- 1 citationsImpact of MRI/US fusion-guided prostate biopsy on biopsy-naïve patients: A single urologist's experience.Muammer Altok, Cihan Demirel, Hyunseon C Kang, Haesun Choi, David John, Irene A Inguillo, John W Davis, John F Ward> ;BJUI Compass. 2022 Jan 1
- 67 citationsDefinitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trialChad Tang, Pavlos Msaouel, Kieko Hara, Haesun Choi, Venus Le, Amishi Yogesh Shah, Jennifer Wang, Eric Jonasch, Seungtaek Choi, Quynh-Nhu Nguyen, Prajnan Das, Surendra ...> ;The Lancet. Oncology. 2021 Oct 28
- Join now to see all
Press Mentions
Tumor Response Criteria for Assessing Pazopanib First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma (mRCC)June 1st, 2020
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
